Clinical Decision Support
AI-powered recommendations and clinical guidelines
12
Active Recommendations
95%
Avg Confidence
8
Guidelines Matched
Clinical Recommendations
Evidence-based clinical guidance
💊
Consider PARP Inhibitor Therapy
Patient with BRCA1 pathogenic variant may benefit from PARP inhibitor treatment.
high priority
Evidence: Level 1 Evidence (RCT)
Confidence: 95%
🧬
Family Cascade Testing Recommended
First-degree relatives should be offered genetic testing for identified BRCA1 variant.
medium priority
Evidence: Clinical Guidelines
Confidence: 90%